Pre-order Enquiry
Request Free Sample
Global and China Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020-2026
SKU ID : QYR-16366042 | Publishing Date : 03-Sep-2020 | No. of pages : 96
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global and China Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020-2026
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Protein Detection
1.2.3 DNA Detection
1.3 Market by Application
1.3.1 Global Companion Diagnostic Tests in Oncology Market Share by Application: 2020 VS 2026
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Medical Device Companies
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Tests in Oncology Market Perspective (2015-2026)
2.2 Global Companion Diagnostic Tests in Oncology Growth Trends by Regions
2.2.1 Companion Diagnostic Tests in Oncology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Companion Diagnostic Tests in Oncology Historic Market Share by Regions (2015-2020)
2.2.3 Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Tests in Oncology Players by Market Size
3.1.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue (2015-2020)
3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2015-2020)
3.2 Global Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue
3.4 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio
3.4.1 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests in Oncology Revenue in 2019
3.5 Key Players Companion Diagnostic Tests in Oncology Area Served
3.6 Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Tests in Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Tests in Oncology Breakdown Data by Type (2015-2026)
4.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Type (2015-2020)
4.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2021-2026)
5 Companion Diagnostic Tests in Oncology Breakdown Data by Application (2015-2026)
5.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Application (2015-2020)
5.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Companion Diagnostic Tests in Oncology Market Size (2015-2026)
6.2 North America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
6.3 North America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
6.4 North America Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Companion Diagnostic Tests in Oncology Market Size (2015-2026)
7.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
7.4 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Companion Diagnostic Tests in Oncology Market Size (2015-2026)
8.2 China Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
8.3 China Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
8.4 China Companion Diagnostic Tests in Oncology Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Companion Diagnostic Tests in Oncology Market Size (2015-2026)
9.2 Japan Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
9.3 Japan Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
9.4 Japan Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Companion Diagnostic Tests in Oncology Market Size (2015-2026)
10.2 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
10.3 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
10.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Companion Diagnostic Tests in Oncology Introduction
11.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020))
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Companion Diagnostic Tests in Oncology Introduction
11.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.2.5 Roche Recent Development
11.3 Genomic Health
11.3.1 Genomic Health Company Details
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Introduction
11.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.3.5 Genomic Health Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Introduction
11.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.4.5 QIAGEN Recent Development
11.5 Agilent
11.5.1 Agilent Company Details
11.5.2 Agilent Business Overview
11.5.3 Agilent Companion Diagnostic Tests in Oncology Introduction
11.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.5.5 Agilent Recent Development
11.6 Agendia
11.6.1 Agendia Company Details
11.6.2 Agendia Business Overview
11.6.3 Agendia Companion Diagnostic Tests in Oncology Introduction
11.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.6.5 Agendia Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Introduction
11.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.7.5 BioMerieux Recent Development
11.8 Illumina
11.8.1 Illumina Company Details
11.8.2 Illumina Business Overview
11.8.3 Illumina Companion Diagnostic Tests in Oncology Introduction
11.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.8.5 Illumina Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Details
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Introduction
11.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.9.5 Siemens Healthcare Recent Development
11.10 Thermo Fisher
11.10.1 Thermo Fisher Company Details
11.10.2 Thermo Fisher Business Overview
11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Introduction
11.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.10.5 Thermo Fisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and China Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Protein Detection
Table 4. Key Players of DNA Detection
Table 5. Global Companion Diagnostic Tests in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Companion Diagnostic Tests in Oncology Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Companion Diagnostic Tests in Oncology Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2015-2020)
Table 9. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2021-2026)
Table 11. Companion Diagnostic Tests in Oncology Market Market Trends
Table 12. Companion Diagnostic Tests in Oncology Market Drivers
Table 13. Companion Diagnostic Tests in Oncology Market Challenges
Table 14. Companion Diagnostic Tests in Oncology Market Restraints
Table 15. Global Companion Diagnostic Tests in Oncology Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Companion Diagnostic Tests in Oncology Market Share by Players (2015-2020)
Table 17. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2019)
Table 18. Global Companion Diagnostic Tests in Oncology by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Companion Diagnostic Tests in Oncology Market Size Share by Type (2015-2020)
Table 24. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2021-2026)
Table 25. Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2015-2020)
Table 26. Global Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2021-2026)
Table 28. North America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 30. North America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 32. North America Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020)
Table 34. Europe Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 36. Europe Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 38. Europe Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020)
Table 40. China Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 41. China Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 42. China Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 43. China Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 44. China Companion Diagnostic Tests in Oncology Market Size by Region (US$ Million) (2015-2020)
Table 45. China Companion Diagnostic Tests in Oncology Market Share by Region (2015-2020)
Table 46. Japan Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 48. Japan Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 50. Japan Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020)
Table 52. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 54. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 56. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020)
Table 58. Abbott Company Details
Table 59. Abbott Business Overview
Table 60. Abbott Product
Table 61. Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 62. Abbott Recent Development
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Product
Table 66. Roche Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 67. Roche Recent Development
Table 68. Genomic Health Company Details
Table 69. Genomic Health Business Overview
Table 70. Genomic Health Product
Table 71. Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 72. Genomic Health Recent Development
Table 73. QIAGEN Company Details
Table 74. QIAGEN Business Overview
Table 75. QIAGEN Product
Table 76. QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 77. QIAGEN Recent Development
Table 78. Agilent Company Details
Table 79. Agilent Business Overview
Table 80. Agilent Product
Table 81. Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 82. Agilent Recent Development
Table 83. Agendia Company Details
Table 84. Agendia Business Overview
Table 85. Agendia Product
Table 86. Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 87. Agendia Recent Development
Table 88. BioMerieux Company Details
Table 89. BioMerieux Business Overview
Table 90. BioMerieux Product
Table 91. BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 92. BioMerieux Recent Development
Table 93. Illumina Business Overview
Table 94. Illumina Product
Table 95. Illumina Company Details
Table 96. Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 97. Illumina Recent Development
Table 98. Siemens Healthcare Company Details
Table 99. Siemens Healthcare Business Overview
Table 100. Siemens Healthcare Product
Table 101. Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 102. Siemens Healthcare Recent Development
Table 103. Thermo Fisher Company Details
Table 104. Thermo Fisher Business Overview
Table 105. Thermo Fisher Product
Table 106. Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 107. Thermo Fisher Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Tests in Oncology Market Share by Type: 2020 VS 2026
Figure 2. Protein Detection Features
Figure 3. DNA Detection Features
Figure 4. Global Companion Diagnostic Tests in Oncology Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical & Biotechnology Companies Case Studies
Figure 6. Medical Device Companies Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Companion Diagnostic Tests in Oncology Report Years Considered
Figure 9. Global Companion Diagnostic Tests in Oncology Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Companion Diagnostic Tests in Oncology Market Share by Regions: 2020 VS 2026
Figure 11. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2021-2026)
Figure 12. Global Companion Diagnostic Tests in Oncology Market Share by Players in 2019
Figure 13. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests in Oncology Revenue in 2019
Figure 15. North America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Abbott Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 43. Roche Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 44. Genomic Health Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 45. QIAGEN Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 46. Agilent Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 47. Agendia Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 48. BioMerieux Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 49. Illumina Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 50. Siemens Healthcare Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 51. Thermo Fisher Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Keyplayers in Global and China Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020-2026
AbbottRoche
Genomic Health
QIAGEN
Agilent
Agendia
BioMerieux
Illumina
Siemens Healthcare
Thermo Fisher
